View in EDS HTML Full Text PDF Full Text

Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy.

Saved in:

Bibliographic Details
Title:	Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy.
Authors:	Roberti, Roberta¹ (AUTHOR), Politi, Cristina^1,2 (AUTHOR), Anzellotti, Francesca³ (AUTHOR), Belcastro, Vincenzo⁴ (AUTHOR), Beretta, Simone⁵ (AUTHOR), Boero, Giovanni⁶ (AUTHOR), Bonanni, Paolo⁷ (AUTHOR), Canafoglia, Laura⁸ (AUTHOR), D'Aniello, Alfredo⁹ (AUTHOR), Dainese, Filippo¹⁰ (AUTHOR), De Caro, Carmen^1,11 (AUTHOR), Di Gennaro, Giancarlo⁹ (AUTHOR), Di Giacomo, Roberta¹² (AUTHOR), DiFrancesco, Jacopo C.⁵ (AUTHOR), Dono, Fedele^3,13 (AUTHOR), Falcicchio, Giovanni¹⁴ (AUTHOR), Ferlazzo, Edoardo^15,16 (AUTHOR), Foschi, Nicoletta¹⁷ (AUTHOR), Gambardella, Antonio¹⁸ (AUTHOR), Giordano, Alfonso¹⁹ (AUTHOR)
Source:	Neurology & Therapy. Feb2026, Vol. 15 Issue 1, p213-235. 23p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!